Logo image of DUOT

DUOS TECHNOLOGIES GROUP INC (DUOT) Stock Fundamental Analysis

NASDAQ:DUOT - Nasdaq - US2660424076 - Common Stock - Currency: USD

5.55  +0.33 (+6.32%)

After market: 5.55 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DUOT. DUOT was compared to 281 industry peers in the Software industry. Both the profitability and financial health of DUOT have multiple concerns. While showing a medium growth rate, DUOT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DUOT had negative earnings in the past year.
DUOT had a negative operating cash flow in the past year.
In the past 5 years DUOT always reported negative net income.
DUOT had a negative operating cash flow in each of the past 5 years.
DUOT Yearly Net Income VS EBIT VS OCF VS FCFDUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -47.76%, DUOT is doing worse than 83.63% of the companies in the same industry.
The Return On Equity of DUOT (-418.67%) is worse than 84.70% of its industry peers.
Industry RankSector Rank
ROA -47.76%
ROE -418.67%
ROIC N/A
ROA(3y)-67.78%
ROA(5y)-70.66%
ROE(3y)-383.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DUOT Yearly ROA, ROE, ROICDUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K 1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 15.01%, DUOT is doing worse than 85.05% of the companies in the same industry.
DUOT's Gross Margin has declined in the last couple of years.
DUOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y80.38%
GM growth 5Y-16.5%
DUOT Yearly Profit, Operating, Gross MarginsDUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

DUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DUOT has more shares outstanding
Compared to 5 years ago, DUOT has more shares outstanding
Compared to 1 year ago, DUOT has an improved debt to assets ratio.
DUOT Yearly Shares OutstandingDUOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
DUOT Yearly Total Debt VS Total AssetsDUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -4.49, we must say that DUOT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DUOT (-4.49) is worse than 81.49% of its industry peers.
DUOT has a Debt/Equity ratio of 0.71. This is a neutral value indicating DUOT is somewhat dependend on debt financing.
DUOT's Debt to Equity ratio of 0.71 is on the low side compared to the rest of the industry. DUOT is outperformed by 69.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -4.49
ROIC/WACCN/A
WACC12.77%
DUOT Yearly LT Debt VS Equity VS FCFDUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

DUOT has a Current Ratio of 0.73. This is a bad value and indicates that DUOT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of DUOT (0.73) is worse than 85.05% of its industry peers.
DUOT has a Quick Ratio of 0.73. This is a bad value and indicates that DUOT is not financially healthy enough and could expect problems in meeting its short term obligations.
DUOT has a Quick ratio of 0.56. This is amonst the worse of the industry: DUOT underperforms 89.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.56
DUOT Yearly Current Assets VS Current LiabilitesDUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for DUOT have decreased strongly by -16.26% in the last year.
Looking at the last year, DUOT shows a very negative growth in Revenue. The Revenue has decreased by -38.12% in the last year.
Measured over the past years, DUOT shows a decrease in Revenue. The Revenue has been decreasing by -9.12% on average per year.
EPS 1Y (TTM)-16.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.1%
Revenue 1Y (TTM)-38.12%
Revenue growth 3Y-2.42%
Revenue growth 5Y-9.12%
Sales Q2Q%111.57%

3.2 Future

DUOT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.18% yearly.
The Revenue is expected to grow by 72.75% on average over the next years. This is a very strong growth
EPS Next Y17.17%
EPS Next 2Y32.9%
EPS Next 3Y29.18%
EPS Next 5YN/A
Revenue Next Year-4.05%
Revenue Next 2Y65.03%
Revenue Next 3Y72.75%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DUOT Yearly Revenue VS EstimatesDUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
DUOT Yearly EPS VS EstimatesDUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DUOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DUOT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DUOT Price Earnings VS Forward Price EarningsDUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DUOT Per share dataDUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

DUOT's earnings are expected to grow with 29.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.9%
EPS Next 3Y29.18%

More info and screens

0

5. Dividend

5.1 Amount

DUOT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DUOS TECHNOLOGIES GROUP INC

NASDAQ:DUOT (3/7/2025, 8:20:35 PM)

After market: 5.55 0 (0%)

5.55

+0.33 (+6.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-19 2024-11-19/amc
Earnings (Next)03-31 2025-03-31/amc
Inst Owners29.25%
Inst Owner Change-0.4%
Ins Owners27.03%
Ins Owner Change0.31%
Market Cap46.68M
Analysts82.5
Price Target10.97 (97.66%)
Short Float %1.46%
Short Ratio0.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.83%
Min EPS beat(2)-27.75%
Max EPS beat(2)29.41%
EPS beat(4)2
Avg EPS beat(4)-17.23%
Min EPS beat(4)-72.55%
Max EPS beat(4)29.41%
EPS beat(8)4
Avg EPS beat(8)-20.3%
EPS beat(12)7
Avg EPS beat(12)-12.81%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.94%
Min Revenue beat(2)13.41%
Max Revenue beat(2)18.47%
Revenue beat(4)2
Avg Revenue beat(4)-10.82%
Min Revenue beat(4)-50.13%
Max Revenue beat(4)18.47%
Revenue beat(8)3
Avg Revenue beat(8)-15.73%
Revenue beat(12)5
Avg Revenue beat(12)-7.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)22.86%
PT rev (3m)34.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-31.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-37.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-29.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.35
P/FCF N/A
P/OCF N/A
P/B 18.58
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.43
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)-1.11
OCFYN/A
SpS0.87
BVpS0.3
TBVpS-0.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.76%
ROE -418.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.01%
FCFM N/A
ROA(3y)-67.78%
ROA(5y)-70.66%
ROE(3y)-383.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y80.38%
GM growth 5Y-16.5%
F-Score2
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 107.42%
Cap/Sales 23.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.56
Altman-Z -4.49
F-Score2
WACC12.77%
ROIC/WACCN/A
Cap/Depr(3y)192.7%
Cap/Depr(5y)166.43%
Cap/Sales(3y)8.52%
Cap/Sales(5y)6.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.1%
EPS Next Y17.17%
EPS Next 2Y32.9%
EPS Next 3Y29.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.12%
Revenue growth 3Y-2.42%
Revenue growth 5Y-9.12%
Sales Q2Q%111.57%
Revenue Next Year-4.05%
Revenue Next 2Y65.03%
Revenue Next 3Y72.75%
Revenue Next 5YN/A
EBIT growth 1Y-20.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.13%
EBIT Next 3Y37.12%
EBIT Next 5YN/A
FCF growth 1Y-98.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.61%
OCF growth 3YN/A
OCF growth 5YN/A